La catena delle opzioni mostra i dati chiave delle opzioni azionarie di H.B. Fuller a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per H.B. Fuller..

H.B. Fuller (NYSE:FUL) Azioni, Catena delle Opzioni

H.B. Fuller

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

H.B. Fuller Co

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics Inc

FULHAM SHORE PLC by FULHAM SHORE PLC

FULLNET COMMUNS INC by FullNet Communications, Inc.

Fullnet Communications Inc

Fulton Financial Corporation - Common Stock

Fulton Financial Corp

Fulton Financial Corporation - Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A

Baird analyst Ghansham Panjabi maintains H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) with a Outperform and raises the price target from $60 to $75.

News

Price Target

Analyst Ratings

Baird Maintains Outperform on H.B. Fuller, Raises Price Target to $75

JP Morgan analyst Jeffrey Zekauskas maintains H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) with a Underweight and raises the price target from $50 to $54.

JP Morgan Maintains Underweight on H.B. Fuller, Raises Price Target to $54

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Thursday.
Shares of H.B. Fuller Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) rose sharply in Thursday's session after the company reported better-than-expected second-quarter earnings and raised its FY2025 adjusted EPS <a href="https://www.benzinga.com/quote/FUL/earnings">guidance above estimates</a>.
H.B. Fuller reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $1.08 per share. The company reported quarterly sales of $898.095 million which missed the analyst consensus estimate of $899.955 million.
H.B. Fuller shares jumped 10.8% to $61.60 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>BlackSky Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NASDAQ">BKSY</a>) shares jumped 16.5% to $20.12. Canaccord Genuity analyst Austin Moeller maintained BlackSky Technology with a Buy and raised the price target from $14 to $20.</li>
<li>TSS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) gained 16.5% to $31.68.</li>
<li>Worthington Steel, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) gained 14.5% to $30.06 as the company reported stronger-than-expected financial results for the fourth quarter.</li>
<li>Rocket Lab Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) climbed 13.5% to $36.72.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) gained 13.1% to $15.15.</li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) rose 12.5% to $35.80.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) gained 12.2% to $5.40.</li>
<li>Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) surged 11% to $220.66.</li>
<li>VEON Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) gained 10.7% to $45.17.</li>
<li>Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) shares rose 10.6% to $42.18.</li>
<li>Oscar Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) jumped 10% to $21.08.</li>
<li>Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) gained 10% to $5.96.</li>
<li>AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) rose 9.8% to $258.01. AeroVironment recently reported better-than-expected quarterly financial results.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) gained 9% to $24.48.</li>
<li>MillerKnoll, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) rose 6% to $18.64 after the company reported better-than-expected quarterly EPS and sales.</li>
<li>Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) gained 5.5% to $29.73.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46093486/top-2-utilities-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Utilities Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

Movers

Trading Ideas

AVAV

BBAI

BlackSky Technology Inc. Class A Common Stock

BKSY

CRCL

ENPH

FWRD

LZMH

MLKN

NNNN

OSCR

RKLB

TSSI

VEON

H.B. Fuller Posts Better-Than-Expected Earnings, Joins AeroVironment, MillerKnoll And Other Big Stocks Moving Higher On Thursday

WIIM

H.B. Fuller shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised its FY2025 adjusted EPS guidance above estimates.

H.B. Fuller shares are trading higher after the company raised its FY2025 Adj. EPS guidance.

H.B. Fuller Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) today reported financial results for its second quarter that ended May 31, 2025.
 Fiscal 2025 Outlook:
As a result of our strong financial performance, we are updating our previously communicated financial guidance for fiscal 2025 as follows:
<ul>
<li>Net revenue for fiscal 2025 is now expected to be down 2% to 3%; organic revenue for fiscal 2025 is still expected to be flat to up 2%; we now expect foreign exchange to adversely impact net revenue by 1.0% to 1.5%;</li>
<li>Adjusted EBITDA for fiscal 2025 is now expected to be in the range of $615 million to $630 million, equating to growth of 4% to 6% year-on-year;</li>
<li>Adjusted EPS (diluted) is now expected to be in the range of $4.10 to $4.30, equating to growth of 7% to 12% year-on-year;</li>
<li>Fully diluted shares outstanding for fiscal 2025 is now expected to be in the range of 55 million to 56 million;</li>
<li>Adjusted EBITDA for the third quarter of 2025 is expected to be in the range of $165 million to $175 million.</li>
</ul>

Guidance

H.B. Fuller Now Expects FY25 Revenue To Be Down 2% - 3%; Now Sees FY25 Organic Revenue To Be Flat To Up 2%

H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) raises FY2025 Adj EPS guidance from $3.90-$4.20 to $4.10-$4.30 vs $4.08 analyst estimate..

H.B. Fuller Raises FY2025 Adj EPS Guidance from $3.90-$4.20 to $4.10-$4.30 vs $4.08 Est

H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $1.08 by 9.46 percent. This is a 5.36 percent increase over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $898.095 million which missed the analyst consensus estimate of $899.955 million by 0.21 percent. This is a 2.07 percent decrease over sales of $917.107 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

H.B. Fuller Q2 Adj. EPS $1.18 Beats $1.08 Estimate, Sales $898.095M Miss $899.955M Estimate

H.B. Fuller Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) will release earnings results for the second quarter, after the <a href="https://www.benzinga.com/quote/FUL/earnings">closing bell on Wednesday, June 25.</a>
Analysts expect the Saint Paul, Minnesota-based company to report quarterly earnings at $1.08 per share, on revenue of $899.95 million, according to data from Benzinga Pro.
On April 15, H.B. Fuller raised its quarterly dividend by 5.6%.
H.B. Fuller shares gained 1.3% to close at $56.88 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/ful/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Baird analyst Ghansham Panjabi upgraded the stock from Neutral to Outperform with a price target of $60 on April 17, 2025. This analyst has an accuracy rate of 78%.</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Underweight rating and cut the price target from $60 to $50 on March 28, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Seaport Global analyst Michael Harrison downgraded the stock from Buy to Neutral on March 5, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Deutsche Bank analyst David Begleiter maintained a Buy rating and cut the price target from $75 to $72 on Jan. 22, 2025. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying FUL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/ful/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="563" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25034034/image-369-1024x563.png" alt="" class="wp-image-961065" style="width:619px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25034034/image-369-1024x563.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25034034/image-369-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25034034/image-369-768x422.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25034034/image-369.png 1152w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46072226/top-3-real-estate-stocks-you-may-want-to-dump-in-june">Top 3 Real Estate Stocks You May Want To Dump In June</a> </li>
</ul>
Photo via Shutterstock

Top Wall Street Forecasters Revamp H.B. Fuller Expectations Ahead Of Q2 Earnings

<h3>Companies Reporting Before The Bell</h3>
• Novagold Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NG#AMEX">NG</a>) is projected to report earnings for its second quarter. 
• Daktronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAKT#NASDAQ">DAKT</a>) is likely to report quarterly earnings at $0.14 per share on revenue of $189.10 million. 
• Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) is expected to report quarterly earnings at $0.79 per share on revenue of $774.81 million. 
• Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) is expected to report quarterly earnings at $1.19 per share on revenue of $1.43 billion. 
• General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) is projected to report quarterly earnings at $0.71 per share on revenue of $4.59 billion. 
• Crown Crafts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWS#NASDAQ">CRWS</a>) is likely to report earnings for its fourth quarter. 
• Lotus Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) is expected to report earnings for its first quarter. 
<h3>Companies Reporting After The Bell</h3>
• Jefferies Financial Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) is projected to report quarterly earnings at $0.44 per share on revenue of $1.56 billion. 
• Culp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CULP#NYSE">CULP</a>) is expected to report quarterly loss at $0.10 per share on revenue of $52.40 million. 
• Worthington Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) is estimated to report quarterly earnings at $0.83 per share on revenue of $765.60 million. 
• H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) is likely to report quarterly earnings at $1.08 per share on revenue of $899.95 million. 
• MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) is estimated to report quarterly earnings at $0.44 per share on revenue of $913.80 million. 
• Energy Transfer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $126.55 million. 
• Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) is projected to report quarterly earnings at $1.61 per share on revenue of $8.85 billion. 
• Euroholdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHLD#NASDAQ">EHLD</a>) is projected to report earnings for its first quarter. 
• Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) is expected to report quarterly earnings at $0.13 per share on revenue of $759.90 million. 
• Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) is projected to report earnings for its fourth quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRWS

CULP

DAKT

EHLD

KEQU

PAYX

Earnings Scheduled For June 25, 2025

H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) underwent analysis by 3 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $60.67, a high estimate of $72.00, and a low estimate of $50.00. A decline of 6.66% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1744891297_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The perception of H.B. Fuller by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Ghansham Panjabi &#x7C;Baird &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Jeffrey Zekauskas &#x7C;JP Morgan &#x7C;Lowers &#x7C;Underweight &#x7C; $50.00&#x7C;$60.00 &#x7C; 
&#x7C;David Begleiter &#x7C;Deutsche Bank &#x7C;Lowers &#x7C;Buy &#x7C; $72.00&#x7C;$75.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to H.B. Fuller. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of H.B. Fuller compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for H.B. Fuller's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of H.B. Fuller's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FUL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on H.B. Fuller analyst ratings.</a>
<h2>About H.B. Fuller</h2>
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
<h3>H.B. Fuller's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: H.B. Fuller's revenue growth over a period of 3M has faced challenges. As of 28 February, 2025, the company experienced a revenue decline of approximately -2.68%. This indicates a decrease in the company's top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: H.B. Fuller's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 1.68%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): H.B. Fuller's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 0.73%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): H.B. Fuller's ROA stands out, surpassing industry averages. With an impressive ROA of 0.27%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.23, caution is advised due to increased financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into H.B. Fuller Stock: Analyst Perspectives (3 Ratings)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird analyst Ghansham Panjabi upgraded the rating for H.B. Fuller Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) from Neutral to Outperform and maintained the price target of $60. H.B. Fuller shares closed at $52.35 on Wednesday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc analyst Noah Zatzkin upgraded the rating for YETI Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) from Underweight to Sector Weight. YETI shares closed at $26.94 on Wednesday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Anthony Chukumba upgraded Warby Parker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRBY#NYSE">WRBY</a>) from Hold to Buy and announced a $27 price target. Warby Parker shares closed at $14.26 on Wednesday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Vikram Bagri upgraded the rating for Canadian Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) from Sell to Neutral and announced a price target of $8. Canadian Solar shares closed at $7.18 on Wednesday. <a href="https://www.benzinga.com/quote/CSIQ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Vikram Bagri upgraded Generac Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNRC#NYSE">GNRC</a>) from Neutral to Buy but lowered the price target from $162 to $138. Generac shares closed at $110.65 on Wednesday.  <a href="https://www.benzinga.com/quote/GNRC/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying FUL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="625" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17072537/image-18-1024x625.png" alt="" class="wp-image-876353" style="width:531px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17072537/image-18-1024x625.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17072537/image-18-300x183.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17072537/image-18-768x469.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17072537/image-18.png 1076w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44857276/netflix-unitedhealth-group-and-3-stocks-to-watch-heading-into-thursday">Netflix, UnitedHealth Group And 3 Stocks To Watch Heading Into Thursday</a> </li>
</ul>
Photo via Shutterstock

Upgrades

Pre-Market Outlook

CSIQ

GNRC

TARA

URGN

WRBY

YETI

This H.B. Fuller Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Baird analyst Ghansham Panjabi upgrades H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) from Neutral to Outperform and maintains the price target from $60 to $60.

Baird Upgrades H.B. Fuller to Outperform, Maintains Price Target to $60

H.B. Fuller Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) today announced that its Board of Directors approved an increase in the Company's regular quarterly cash dividend from $0.2225 per share of common stock to $0.2350 per share of common stock, payable on May 13, 2025 to shareholders of record at the close of business on April 29, 2025.
This represents a 5.6% increase over the prior quarterly dividend and marks the 56th consecutive year in which the Company has increased its dividend.

Dividends

H.B. Fuller Increases Quarterly Cash Dividend From $0.2225/Shr To $0.2350/Shr, Payable On May 13, 2025 To Shareholders Of Record At Close On April 29, 2025

J.P. Morgan analyst Jeffrey J. Zekauskas maintained an Underweight rating on H. B. Fuller Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) on Thursday, <a target="_blank" href="https://www.benzinga.com/quote/FUL/analyst-ratings" rel="noreferrer noopener">lowering the price forecast from $60 to $50.</a>
The company reported first-quarter results, where net revenue<a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44502655/h-b-fuller-reports-first-quarter-2025-results" rel="noreferrer noopener"> was $789 million,&nbsp;down 2.7% year over year.</a>
Organic revenue was up 1.9% year-on-year, driven by improved volume.
The analyst notes that H.B. Fuller&#8217;s performance showed negative year-over-year comparisons, primarily due to the underperformance of its Health, Hygiene, and Consumable segment.
Despite flat sales in the segment at $368 million, its EBITDA dropped by 25%, from $62.9 million to $46.9 million, continuing a trend of weakness that began in the previous quarter.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44537936/consumer-inflation-expectations-skyrocket-in-march-hit-highest-levels-in-32-years" rel="noreferrer noopener">Consumer Inflation Expectations Skyrocket In March, Hit Highest Levels In 32 Years</a>
Per Zekauskas, this drop was partly due to the company previously benefiting from declining raw material costs, which have now leveled off, leading to reduced price adjustments.
While raw material costs for waxes and tackifying resins increased year-over-year, no sequential inflation was noted.
On the other hand, H.B. Fuller&#8217;s Engineering and Building Adhesive Solutions segments showed more positive results, the analyst writes.
Zekauskas expects H.B. Fuller&#8217;s adjusted EBITDA to grow by about 1% in FY2025, from $594 million to $597 million.
The company is expected to face a negative EBITDA comparison in the first quarter of FY25, with the second quarter EBITDA likely staying flat year-over-year.
The analyst suggests the firm may lower its earnings guidance after 2Q of FY25, especially considering a softer U.S. macro environment. Additionally, Fuller&#8217;s $100 million solar panel business in the Engineering Adhesives segment could see a 20% sales contraction, causing a $5 million year-over-year EBITDA decline due to oversupply in the Chinese solar market.
The key focus for Fuller will be improving price realizations in the HHC segment to restore profitability and margins, the analyst writes.
Price Action: FUL stock is down 5.6% at $54.38 at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44541993/kinder-morgan-set-for-q1-growth-amid-rising-lng-demand-says-analyst" target="_blank" rel="noreferrer noopener">Goldman Sachs Forecasts High Gas Prices And LNG Demand Drive Kinder Morgan&#8217;s Revenue</a></li>
</ul>
Image via Shutterstock.

Analyst Color

Equities

Reiteration

General

JP Morgan Slashes H.B. Fuller Price Forecast For Softening Growth

H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $62.5, with a high estimate of $72.00 and a low estimate of $50.00. Observing a downward trend, the current average is 11.66% lower than the prior average price target of $70.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1743166860_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of H.B. Fuller by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$50.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$72.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$68.00</td>
<td>$78.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to H.B. Fuller. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of H.B. Fuller compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of H.B. Fuller's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of H.B. Fuller's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FUL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on H.B. Fuller analyst ratings.</a>
<h2>About H.B. Fuller</h2>
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
<h3>Key Indicators: H.B. Fuller's Financial Health</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, H.B. Fuller showcased positive performance, achieving a revenue growth rate of 2.26% as of 30 November, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: H.B. Fuller's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -0.8%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -0.4%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): H.B. Fuller's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.15%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: H.B. Fuller's debt-to-equity ratio is below the industry average at 1.13, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: H.B. Fuller In The Eyes Of 4 Experts

JP Morgan analyst Jeffrey Zekauskas maintains H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) with a Underweight and lowers the price target from $60 to $50.

JP Morgan Maintains Underweight on H.B. Fuller, Lowers Price Target to $50

H.B. Fuller shares are trading higher after the company reported better-than-expected Q1 financial results.

Operating cash flow in fiscal year 2025 is expected to be between $300 million and $325 million. Adjusted EBITDA for the second quarter of 2025 is expected to be in the range of $150 million to $160 million.

Comments

H.B. Fuller

H.B. Fuller (FUL) Opzioni

H.B. Fuller (NYSE:FUL) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO